NEW YORK, NY / ACCESSWIRE / January 30, 2020 / Broadcast Management Group, Inc. (BMG) has launched a new sports packaging division headed by nine-time Emmy winner and ESPN veteran, Dave Weiler.

Weiler joined Broadcast Management Group in January 2018 to lead the company's broadcast consulting division, which he continues to manage in addition to the sports packaging group. BMG's new sports packaging division provides turn-key production services for sports rights holders, conferences and leagues. For clients who wish to get more out of their live sports coverage, Broadcast Management Group can produce pre and post-game programming or provide a complete wraps operation around your day-of-event programming.

"Our team of experienced producers, directors and operations managers can deliver high-quality, network-level sports coverage at affordable prices," said Dave Weiler, Senior Vice President. "We truly offer our clients complete production solutions with our expertise in live production, events, integration, creative services and staffing", said Andrew Ryback, Executive Vice President of Live Production.

"Over the last few years we have made significant investments in technology that allows us to better serve our clients. We will continue to invest in technology to support our sports packing clients, including mobile units and flight packs", said Todd Mason, Chief Executive Officer.

Broadcast Management Group is an industry leader in live production, event management, system integration, broadcast consulting, creative services and production staffing. The company has operations in New York, Los Angeles, Las Vegas, Chicago, and Washington, DC.

CONTACT: 

Joshua Gallant
Public Relations, Marketing
Broadcast Management Group, Inc.
973.820.5847
jgallant@broadcastmgmt.com

SOURCE: Broadcast Management Group, Inc

ReleaseID: 574586

EXTON, PA / ACCESSWIRE / January 30, 2020 / First Resource Bank (OTCQX:FRSB) announced financial results for the three months and year ended December 31, 2019.

Highlights for the year ended December 31, 2019 included:

Net income grew 7%
Non-interest bearing deposits grew 59%
Total deposits grew 14%
Loans grew 15%
Nonperforming assets to total assets declined 54%
Opened a third branch location in Wayne, Pennsylvania

Glenn B. Marshall, CEO, stated, "2019 was a remarkable year at First Resource Bank. We opened our third retail branch, experienced significant balance sheet growth funded by core deposits, shed legacy problem loans and achieved record profitability. Investments that were made in 2019 increased overhead expenses; however, those decisions were made with the ultimate goal of continuing to increase profitability."

Net income for the quarter ended December 31, 2019 was $628,299, which compares to $690,729 for the previous quarter and $608,737 for the fourth quarter of the prior year.

Net income for the year ended December 31, 2019 was $2,321,768, a 7% increase as compared to the prior year. The increase in net income is primarily attributable to a 12% increase in net interest income and higher non-interest income, partially offset by a higher provision for loan losses and higher non-interest expense. Swap referral fee income totaled $303 thousand in 2019 as compared to none in 2018. Gains on sales of SBA loans totaled $24 thousand in 2019 as compared to $96 thousand in 2018.

Net interest income was $2,871,683 for the quarter ended December 31, 2019 as compared to $2,861,510 for the previous quarter. The net interest margin decreased 8 basis points from 3.81% for the quarter ended September 30, 2019 to 3.73% for the quarter ended December 31, 2019. The overall yield on interest earning assets decreased 14 basis points during the fourth quarter led by a 5 basis point decrease in loan yields to 5.52%. The cost of deposits decreased 6 basis points during the fourth quarter to 1.38%.

Net interest income for the year ended December 31, 2019 was $11,113,630 as compared to $9,927,714 for the year ended December 31, 2018, a 12% improvement. The net interest margin for the year ended December 31, 2019 was 3.81% as compared to 3.89% for the prior year. Loan yields increased 18 basis points to 5.56% in 2019, as compared to 5.38% in the prior year, and the cost of deposits increased 33 basis points to 1.40% in 2019, as compared to 1.07% in 2018.

Non-interest income for the quarter ended December 31, 2019 was $219,674 as compared to $226,669 for the previous quarter and $178,337 for the fourth quarter of the prior year. Swap referral fee income of $81,500 was received in the fourth quarter of 2019, as compared to $107,160 in the third quarter of 2019 and none in the fourth quarter of 2018. There were no gains on sales of SBA loans recognized during the fourth quarter of 2019 or the third quarter of 2019, as compared to $55,075 in the fourth quarter of 2018.

Non-interest income for the year ended December 31, 2019 was $865,195 as compared to $561,266 for the prior year. The increase is mainly attributed to $302,760 in swap referrals fees received in 2019 as compared to none in 2018.

Non-interest expense increased $99 thousand, or 5%, in the three months ended December 31, 2019 as compared to the prior quarter. The increase was primarily due to an increase in salaries and benefits, occupancy, depreciation, professional fees and other costs, partially offset by a decrease in advertising and data processing costs.

Non-interest expense increased $1.0 million, or 14%, in the year ended December 31, 2019 as compared to the prior year. All expense categories increased from the prior year. Marshall stated, "In 2019 we invested in people and the physical expansion of our branch network. This carefully planned increase in expenses did not inhibit the Bank from achieving record annual profitability for 2019."

Deposits grew $5.4 million from $264.4 million at September 30, 2019 to $269.8 million at December 31, 2019. During the fourth quarter, non-interest bearing deposits increased $2.8 million, or 6%, from $47.8 million at September 30, 2019 to $50.6 million at December 31, 2019. Interest-bearing checking balances increased $2.0 million, or 21%, from $9.8 million at September 30, 2019 to $11.8 million at December 31, 2019. Money market deposits increased $530 thousand, or 1%, from $101.9 million at September 30, 2019 to $102.4 million at December 31, 2019. Certificates of deposit increased $10 thousand, or 0%, from $104.9 million at September 30, 2019 to $105.0 million at December 31, 2019.

During 2019, total deposits increased $33.6 million, or 14%, from $236.2 million at December 31, 2018 to $269.8 million at December 31, 2019. During 2019, non-interest bearing deposits grew 59%, interest checking deposits grew 7%, money market deposits grew 1% and certificates of deposit grew 15%.

Marshall stated, "Over the past few years we have invested in the retail team and this tremendous core deposit growth is attributed to that investment. All employees across the Bank are focused on generating core deposits and the team had some major successes in 2019."

The loan portfolio grew $5.4 million during the fourth quarter from $274.8 million at September 30, 2019 to $280.2 million at December 31, 2019, with growth in commercial real estate loans and construction loans partially offset by a decline in commercial business and consumer loans.

During 2019, the loan portfolio grew $35.5 million, or 15%, from $244.7 at December 31, 2018 to $280.2 million at December 31, 2019, with the majority of that growth in commercial real estate loans.

The following table illustrates the composition of the loan portfolio:

Dec. 31,

2019

Dec. 31,

2018

Commercial real estate

 
$ 
203,427,712
 
 
$ 
170,738,479
 

Commercial construction

 
 
29,353,830
 
 
 
20,377,108
 

Commercial business

 
 
30,805,290
 
 
 
31,738,443
 

Consumer

 
 
16,615,540
 
 
 
21,843,647
 

Total loans

 
$ 
280,202,372
 
 
$ 
244,697,677
 

The allowance for loan losses to total loans was 0.90% at December 31, 2019 as compared to 0.90% at September 30, 2019 and 0.81% at December 31, 2018. Non-performing assets consisted of non-performing loans of $1.4 million at December 31, 2019, a 54% decrease as compared to the prior quarter primarily due to a decrease in non-performing loans and the sale of other real estate owned during the fourth quarter. Non-performing assets to total assets improved 55% from 0.94% at September 30, 2019 to 0.42% at December 31, 2019.

During the year ended December 31, 2019, total stockholder's equity increased $2.7 million, or 11%, from $25.3 million at December 31, 2018 to $28.0 million at December 31, 2019, primarily due to net income generated. During the year ended December 31, 2019 book value per share has grown 94 cents, or 10%, to $10.10.

During the year ended December 31, 2019, total assets grew $34.0 million, or 11%. This growth was primarily the result of $35.5 million in loan growth funded by a $33.6 million increase in deposits.

Selected Financial Data:
Balance Sheets (unaudited)

December 31,

2019

December 31,

2018

Cash and due from banks

 
$ 
2,516,374
 
 
$ 
5,734,677
 

Time deposits at other banks

 
 
599,000
 
 
 
599,000
 

Investments

 
 
37,120,798
 
 
 
37,762,190
 

Loans

 
 
280,202,372
 
 
 
244,697,677
 

Allowance for loan losses

 
 
(2,507,845
)
 
 
(1,990,253
)

Premises & equipment

 
 
8,675,596
 
 
 
6,647,166
 

Other assets

 
 
9,812,630
 
 
 
8,996,941
 

Total assets

 
$ 
336,418,925
 
 
$ 
302,447,398
 

Non-interest bearing deposits

 
$ 
50,616,321
 
 
$ 
31,788,359
 

Interest-bearing checking

 
 
11,797,456
 
 
 
11,069,325
 

Money market

 
 
102,433,910
 
 
 
101,887,847
 

Time deposits

 
 
104,952,207
 
 
 
91,456,365
 

Total deposits

 
 
269,799,894
 
 
 
236,201,896
 

Short term borrowings

 
 
10,896,000
 
 
 
17,000,400
 

Long term borrowings

 
 
21,045,500
 
 
 
18,515,500
 

Subordinated debt

 
 
3,994,591
 
 
 
3,986,097
 

Other liabilities

 
 
2,705,583
 
 
 
1,466,037
 

Total liabilities

 
 
308,441,568
 
 
 
277,169,930
 

Total stockholders' equity

 
 
27,977,357
 
 
 
25,277,468
 

Total liabilities & stockholders' equity

 
$ 
336,418,925
 
 
$ 
302,447,398
 

Performance Statistics
(unaudited)

Qtr Ended

Dec. 31,

2019

Qtr Ended

Sept. 30,

2019

Qtr Ended

June 30,

2019

Qtr Ended

Mar. 31,

2019

Qtr Ended

Dec. 31,

2018

Net interest margin

 
 
3.73
%
 
 
3.81
%
 
 
3.85
%
 
 
3.87
%
 
 
3.78
%

Nonperforming loans/

Total loans

 
 
0.50
%
 
 
0.89
%
 
 
0.83
%
 
 
0.87
%
 
 
1.14
%

Nonperforming assets/

Total assets

 
 
0.42
%
 
 
0.94
%
 
 
0.91
%
 
 
0.74
%
 
 
0.92
%

Allowance for loan losses/

Total loans

 
 
0.90
%
 
 
0.90
%
 
 
0.93
%
 
 
0.95
%
 
 
0.81
%

Average loans/Average

assets

 
 
84.9
%
 
 
87.2
%
 
 
87.4
%
 
 
86.5
%
 
 
84.9
%

Non-interest expenses*/

Average assets

 
 
2.75
%
 
 
2.71
%
 
 
2.75
%
 
 
2.60
%
 
 
2.67
%

Earnings per share – basic

and diluted **

 
$
0.23
 
 
$
0.25
 
 
$
0.23
 
 
$
0.13
 
 
$
0.22
 

Book value per share **

 
$
10.10
 
 
$
9.88
 
 
$
9.63
 
 
$
9.35
 
 
$
9.16
 

Total shares outstanding **

 
 
2,768,729
 
 
 
2,766,330
 
 
 
2,764,241
 
 
 
2,761,910
 
 
 
2,759,808
 

* Annualized
** Per share data has been restated to reflect 5% stock dividend paid in May 2019.

Year Ended

Dec. 31,

2019

Year Ended

Dec. 31,

2018

Net interest margin

 
 
3.81
%
 
 
3.89
%

Return on assets

 
 
0.76
%
 
 
0.81
%

Return on equity

 
 
8.72
%
 
 
9.02
%

Earnings per share-basic and diluted

 
$
0.84
 
 
$
0.79
 

Income Statements (unaudited)

Qtr. Ended

Dec. 31,

2019

Qtr. Ended

Sept. 30,

2019

Qtr. Ended

June 30,

2019

Qtr. Ended

Mar. 31,

2019

Qtr. Ended

Dec. 31,

2018

INTEREST INCOME

Loans, including fees

 
$ 
3,819,667
 
 
$ 
3,855,582
 
 
$ 
3,679,137
 
 
$ 
3,438,752
 
 
$ 
3,297,459
 

Securities

 
 
129,178
 
 
 
124,908
 
 
 
126,881
 
 
 
128,301
 
 
 
124,207
 

Other

 
 
38,987
 
 
 
18,348
 
 
 
13,428
 
 
 
29,310
 
 
 
37,950
 

Total interest income

 
 
3,987,832
 
 
 
3,998,838
 
 
 
3,819,446
 
 
 
3,596,363
 
 
 
3,459,616
 

INTEREST EXPENSE

Deposits

 
 
930,953
 
 
 
938,804
 
 
 
886,280
 
 
 
800,541
 
 
 
739,464
 

Borrowings

 
 
117,350
 
 
 
130,679
 
 
 
111,271
 
 
 
102,671
 
 
 
108,664
 

Subordinated debt

 
 
67,846
 
 
 
67,845
 
 
 
67,485
 
 
 
67,124
 
 
 
67,843
 

Total interest expense

 
 
1,116,149
 
 
 
1,137,328
 
 
 
1,065,036
 
 
 
970,336
 
 
 
915,971
 

Net interest income

 
 
2,871,683
 
 
 
2,861,510
 
 
 
2,754,410
 
 
 
2,626,027
 
 
 
2,543,645
 

Provision for loan losses

 
 
66,628
 
 
 
84,557
 
 
 
158,992
 
 
 
475,952
 
 
 
78,051
 

Net interest income after provision for loan losses

 
 
2,805,055
 
 
 
2,776,953
 
 
 
2,595,418
 
 
 
2,150,075
 
 
 
2,465,594
 

NON-INTEREST INCOME

BOLI income

 
 
38,067
 
 
 
38,205
 
 
 
37,965
 
 
 
37,455
 
 
 
38,315
 

Swap referral fee income

 
 
81,500
 
 
 
107,160
 
 
 
114,100
 
 
 
–
 
 
 
–
 

Gain on sale of SBA loans

 
 
–
 
 
 
–
 
 
 
–
 
 
 
24,463
 
 
 
55,075
 

Other

 
 
100,107
 
 
 
81,304
 
 
 
110,532
 
 
 
94,337
 
 
 
84,947
 

Total non-interest income

 
 
219,674
 
 
 
226,669
 
 
 
262,597
 
 
 
156,255
 
 
 
178,337
 

NON-INTEREST EXPENSE

Salaries & benefits

 
 
1,267,867
 
 
 
1,266,493
 
 
 
1,238,114
 
 
 
1,053,586
 
 
 
1,121,757
 

Occupancy & equipment

 
 
251,297
 
 
 
189,381
 
 
 
185,402
 
 
 
191,572
 
 
 
179,256
 

Professional fees

 
 
94,744
 
 
 
88,083
 
 
 
101,117
 
 
 
100,169
 
 
 
94,756
 

Advertising

 
 
54,660
 
 
 
82,357
 
 
 
35,401
 
 
 
33,764
 
 
 
34,689
 

Data processing

 
 
127,721
 
 
 
142,587
 
 
 
135,151
 
 
 
127,119
 
 
 
121,363
 

Other

 
 
447,905
 
 
 
376,707
 
 
 
380,297
 
 
 
347,391
 
 
 
337,137
 

Total non-interest

expense

 
 
2,244,194
 
 
 
2,145,608
 
 
 
2,075,482
 
 
 
1,853,601
 
 
 
1,888,958
 

Income before income tax expense

 
 
780,535
 
 
 
858,014
 
 
 
782,533
 
 
 
452,729
 
 
 
754,973
 

Federal income tax expense

 
 
152,236
 
 
 
167,285
 
 
 
151,013
 
 
 
81,509
 
 
 
146,236
 

Net income

 
$ 
628,299
 
 
$ 
690,729
 
 
$ 
631,520
 
 
$ 
371,220
 
 
$ 
608,737
 

Income Statements (unaudited)

Year

Ended
December 31,

2019

Year

Ended
December 31,

2018

INTEREST INCOME

Loans

 
$ 
14,793,138
 
 
$ 
12,403,812
 

Investments

 
 
509,268
 
 
 
496,230
 

Other

 
 
100,073
 
 
 
62,951
 

Total interest income

 
 
15,402,479
 
 
 
12,962,993
 

INTEREST EXPENSE

Deposits

 
 
3,556,578
 
 
 
2,348,864
 

Borrowings

 
 
461,971
 
 
 
416,115
 

Subordinated debt

 
 
270,300
 
 
 
270,300
 

Total interest expense

 
 
4,288,849
 
 
 
3,035,279
 

Net interest income

 
 
11,113,630
 
 
 
9,927,714
 

Provision for loan losses

 
 
786,129
 
 
 
513,238
 

Net interest income after provision for loan losses

 
 
10,327,501
 
 
 
9,414,476
 

NON-INTEREST INCOME

BOLI income

 
 
151,692
 
 
 
149,082
 

Swap referral fee income

 
 
302,760
 
 
 
–
 

Gain on sale of SBA loans

 
 
24,463
 
 
 
96,431
 

Other

 
 
386,280
 
 
 
315,753
 

Total non-interest income

 
 
865,195
 
 
 
561,266
 

NON-INTEREST EXPENSE

Salaries & benefits

 
 
4,826,060
 
 
 
4,294,541
 

Occupancy & equipment

 
 
817,652
 
 
 
730,323
 

Professional fees

 
 
384,113
 
 
 
366,572
 

Advertising

 
 
206,182
 
 
 
195,357
 

Data processing

 
 
532,578
 
 
 
446,542
 

Other non-interest expense

 
 
1,552,300
 
 
 
1,277,305
 

Total non-interest expense

 
 
8,318,885
 
 
 
7,310,640
 

Pre-tax income

 
 
2,873,811
 
 
 
2,665,102
 

Tax expense

 
 
552,043
 
 
 
499,895
 

Net income

 
$ 
2,321,768
 
 
$ 
2,165,207
 

###

About First Resource Bank

First Resource Bank is a locally owned and operated Pennsylvania state-chartered bank with three full-service branches, serving the banking needs of businesses, professionals and individuals in Chester County, Pennsylvania. The Bank offers a full range of deposit and credit services with a high level of personalized service. First Resource Bank also offers a broad range of traditional financial services and products, competitively priced and delivered in a responsive manner to small businesses, professionals and residents in the local market. For additional information visit our website at www.firstresourcebank.com. Member FDIC.

This press release contains statements that are not of historical facts and may pertain to future operating results or events or management's expectations regarding those results or events. These are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. These forward-looking statements may include, but are not limited to, statements about our plans, objectives, expectations and intentions and other statements contained in this press release that are not historical facts. When used in this press release, the words "expects", "anticipates", "intends", "plans", "believes", "seeks", "estimates", or words of similar meaning, or future or conditional verbs, such as "will", "would", "should", "could", or "may" are generally intended to identify forward-looking statements. These forward-looking statements are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are either beyond our control or not reasonably capable of predicting at this time. In addition, these forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Actual results may differ materially from the results discussed in these forward-looking statements. Readers of this press release are accordingly cautioned not to place undue reliance on forward-looking statements. First Resource Bank disclaims any intent or obligation to update publicly any of the forward-looking statements herein, whether in response to new information, future events or otherwise.

Media Contact:
Glenn Marshall, CEO
610-561-6013

SOURCE: First Resource Bank

ReleaseID: 574640

LOS ANGELES, CA / ACCESSWIRE / January 30, 2020 / Ventura Cannabis and Wellness Corp. (CSE:VCAN)("Ventura" or the "Company") releases financial statements for the period ending November 30, 2019. Highlights include:

Cannabis revenue for the quarter was $501,000 as compared to $402,000 last quarter, representing a 24% growth quarter over quarter or 96% annually; organic growth accounts for the overwhelming majority of the revenue growth.

Cannabis Revenue Trend:

FY 2019 – $0
2020 Q1 – $92,000
2020 Q2 – $406,000 (341% increase quarter over quarter)
2020 Q3 – $501,000 (24% increase quarter over quarter)

Gross margins for cannabis operations were 34%, however, as with most U.S. cannabis assets, free cash flow continues to be limited.

Gross Margin Trend:

2019 Q3 – 22%
2020 Q2 – 31%
2020 Q3 – 34%

Cash remained roughly neutral quarter over quarter, as the Company continued to await regulatory approvals for new assets:

2020 Q2 – $4,531,000
2020 Q3 – $4,483,000

Total assets grew to $19,182,000 as accounts payable decreased by $500,000 between Q2 and Q3 of this year.
Management continues to work to dispose of or unwind the addiction services assets, as well as reduce liabilities and define the contingent liabilities more clearly. (see note 7)

"We had a fantastic quarter for revenue growth, the overwhelming majority of which was organic," said Mr. Chris Heath, CEO of Ventura. "For the third quarter in a row we have seen revenue growth, but this quarter was different. We have proven to ourselves and the market that we can acquire brands and businesses and improve them quickly, increasing our market share and reducing our post-acquisition multiple. We are now very well positioned for future revenue growth; first, we have a solid team on the west coast of the U.S. that has years of experience in the full supply chain of cannabis, from seed to sale, with a proven track record for three consecutive quarters. Second, we have contracts in place where we expect to manufacture, distribute and dispense cannabis products in California and Oregon, and we are working on several other west coast states in the U.S. for acquisitions and licenses. Lastly, we have no debt and we are operating our cannabis assets above breakeven."

For future quarters, the management is focused on several key accomplishments to continue market share and revenue growth:

Appoint Lloyd Kaplan as Chairman of the Board, effective March 1st, 2020, with a mandate to initiate capital markets communication and develop relationships in the capital markets to enable continued revenue growth. Because of the taxation and regulatory framework in the U.S, cannabis assets generally do not yet yield significant cash flow. The strategy for all companies in this sector is to build brand loyalty and market share for when the U.S. Federal prohibition is lifted or the U.S. tax frame work is changed. Ventura Cannabis plans to work with capital market participants to continue to fuel revenue growth in future quarters.
Finalize ownership of assets that provide licenses to manufacture, distribute and sell branded products in California and Oregon, focusing on post acquisition revenue growth and generating limited but positive cash flow. These assets are projected to require most of our cash balance, and inorganic revenue growth will be the immediate result of the acquisitions.
Divest from the addiction business units working to reduce liabilities and better understand and deal with potential contingent liabilities. The Company has reserved the majority of its post-acquisition cash for these matters.

For more information contact:

Ventura Cannabis and Wellness Corp.
Chris Heath
CEO
(424) 372-1123
investor@venturacanna.com
www.venturacanna.com

Certain statements contained in this presentation constitute "forward-looking information" as such term is defined in applicable Canadian securities legislation. The words "may," "would," "could," "should," "potential," "will," "seek," "intend," "plan," "anticipate," "believe," "estimate," "expect," "confident" and similar expressions as they relate to the Company. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties, and assumptions. The forward-looking information included are made as of January 30, 2020, and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law. VCAN holds or is acquiring marijuana assets in the United States. Previously disclosed acquisitions are still subject to closing. Marijuana is legal in each state VCAN is looking to operate, however marijuana remains illegal under US federal law, and the approach to enforcement of US federal law against marijuana is subject to change. Shareholders and investors need to be aware that adverse enforcement actions could affect their investments and that the Company's ability to access private and public capital could be affected and or could not be available to support continuing operations.

SOURCE: Ventura Cannabis and Wellness Corp.

ReleaseID: 574643

NEW YORK, NY / ACCESSWIRE / January 30, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Beyond Meat, Inc. ("Beyond Meat" or the Company") (NASDAQ:BYND).Investors who purchased Beyond Meat securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/bynd.

The investigation concerns whether Beyond Meat and certain of its officers and/or directors have violated federal securities laws.

On January 27, 2020, post-market, Don Lee Farms issued a press release entitled "Judge Rules Don Lee Farms Likely to Obtain a Judgment. Beyond Meat's CFO and Others Named Individually for Fraud." The press release stated, in part, that "[a] judge has ruled Don Lee Farms proved the probable validity of its claim that Beyond Meat breached its manufacturing agreement with Don Lee Farms" and that "[i]n a separate motion before a different Judge, the Court granted Don Lee Farms' request to name Beyond Meat Chief Financial Officer Mark Nelson, Senior Quality Assurance Manager Jessica Quetsch and Director of Operations Anthony Miller in its fraud claims which allege they intentionally doctored and omitted material information from a food safety consultant's report, and then delivered that doctored report to Don Lee Farms and affirmatively represented that it was the complete opinion of the consultant." On this news, Beyond Meat's stock price fell sharply during intraday trading on January 28, 2020.

If you are aware of any facts relating to this investigation, or purchased Beyond Meat shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/bynd. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 574639

ATLANTA, GA / ACCESSWIRE / January 30, 2020 / Findit, Inc. (OTC PINK:FDIT) owner of Findit.com, a full service social networking content management platform which provides online marketing services to Twisted Wares, is featuring Findit member Twisted Wares for their hilariously funny kitchen products such as hang tight towels, kitchen aprons and cocktail napkins available to retailers, resellers, and bulk buyers at wholesale prices.

Twisted Wares has the best selection of snarky kitchen products that feature funny graphics, images, hilarious sayings and more. They have a wide variety of funny cocktail napkins, hang tight towels, pillows, and crossback aprons. All of their products feature these funny sayings and images and make great gifts for friends and family and are perfect for checkout stations, window display cases and end caps.

Twisted Wares has claimed 9 Findit Names under the Claim Your Name Feature on Findit. Each of the names represents a type of funny kitchen product or accessory that Twisted Wares sells such as their funny cocktail napkins, bitch bags, or wholesale hang tight towels.

Check Out Some of Twisted Wares Funny Novelty Merchandise

Funny Cluster Fork Crossback Apron

Group Therapy Cocktail Napkin Set

I Farted Here (And Here) Guest Bedroom Pillows

Whip It Good Hang Tight Towel

Twisted Wares funny novelty kitchen products and accessories make great additions to your retail stores, e commerce website or for bulk purchases and resellers. They have a great selection of all of their products so you can find exactly what you want to meet the needs of your customers in your store.

Browse Twisted Wares products for sale online at twistedwares.com. For wholesale pricing, contact Twisted Wares at 214-491-4911 or visit twistedwares-wholesale.com.

Follow Twisted Wares on Findit at findit.com/wholesale-funny-towels.

Findit focuses on reaching the target demographics for each of these members that may or may not be aware of them in an effort to heighten brand awareness of their services and in some cases, their extensive product lines.

About Findit, Inc.
Findit, Inc., owns Findit.com which is a Social Media Content Management Platform that provides an interactive search engine for all content posted in Findit to appear in Findit search. The site is an open platform that provides access to Google, Yahoo, Bing and other search engines access to its content posted to Findit so it can be indexed in these search engines as well. Findit provides Members the ability to post, share and manage their content. Once they have posted in Findit, we ensure the content gets indexed in Findit Search results. Findit provides an option for anyone to submit URLs that they want indexed in Findit search result, along with posting status updates through Findit Right Now. Status Updates posted in Findit can be crawled by outside search engines which can result in additional organic indexing. All posts on Findit can be shared to other social and bookmarking sites by members and non-members. Findit provides Real Estate Agents the ability to create their own Findit Site where they can pull in their listing and others through their IDX account. Findit, Inc., is focused on the development of monetized Internet-based web products that can provide an increase in brand awareness of our members. Findit, Inc., trades under the stock symbol FDIT on the OTCPinksheets.

Safe Harbor:
This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding potential sales, the success of the company's business, as well as statements that include the word believe or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Findit, Inc. to differ materially from those implied or expressed.

Contact:

Clark St. Amant
404-443-3224

SOURCE: Findit, Inc.

ReleaseID: 574638

LONDON, UK / ACCESSWIRE / January 30, 2020 / Waves.Exchange, a hybrid crypto asset exchange platform built into the Waves blockchain, added decentralized staking support for Neutrino dollar (USDN) on January 28, 2020.

As a non-custodial staking solution, Waves.Exchange users are now able to benefit from regular staking rewards, while still retaining full ownership of their funds. This completely risk-free approach makes cryptocurrency staking more accessible than ever before.

The first asset available for staking on the platform is the Neutrino dollar, an algorithmically stable USD-pegged asset that is collateralized with WAVES, the crypto asset that fuels the Waves blockchain platform. Built on the open-source Neutrino protocol, USDN is designed to provide WAVES holders with a way to exit volatility, while opening up additional revenue streams, including staking.

As it stands, the estimated annual yield for staked USDN sits at more than 13%, though this can vary based on the WAVES token capitalization.

To achieve stability, Neutrino uses an algorithm to automatically mint USDN if the WAVES price increases. This is stored in a special reserve fund which will be used to cover the exchange rate difference should WAVES decrease again in the future. This process is assisted by a network of oracles that feed price information to the neutrino smart contract.

If this coverage is insufficient, the smart contract will instead generate a type of bond token, known as USD-NB which can be bought at the current market rate on Waves.Exchange with USDN. This USDN will be used to correct the market deficit, whereas USD-NB can be liquidated based on first-in, first-out (FIFO) principles to help correct the value of USDN.

Since USD-NB can be traded at a floating exchange rate, the bond token also presents an attractive financial instrument for high-risk traders, as USD-NB purchased at below USD parity can be later redeemed to USDN at a 1:1 rate. For example, even if 10 USD-NB are purchased for 8 USDN, these 10 USD-NB can later be liquidated to 10 USDN, a trade that would yield 25% profit.

Unlike many other stablecoins, Neutrino operates with absolute transparency, since the Neutrino smart contract and associated addresses can be freely audited on the public blockchain-essentially eliminating concerns faced by other stablecoins, including suspicions surrounding incomplete backing and delayed emission.

About Waves.Exchange

Waves.Exchange is a hybrid crypto assets exchange that allows users to transfer, trade, issue and stake cryptocurrencies. The platform combines the security of decentralized systems with the features and advantages of conventional centralized exchanges. Established in 2017 as Waves DEX, Waves.Exchange is now a standalone product. Waves.Exchange offers fast and secure trading instruments, staking opportunities, low costs, an API, mobile applications and access to BTC, ETH, LTC, WAVES, USDT, XMR, in addition to many more assets, including 30k+ tokens on the Waves protocol.

Related Links
Waves Exchange: https://waves.exchange/
Github: https://github.com/ventuary-lab
Neutrino dapp: https://beta.neutrino.at/#
Neutrino landing page: https://defi-profits.com/

Contact:
Waves PR
pr@waves.exchange
+972-545-464-238

SOURCE: Waves.Exchange

ReleaseID: 574494

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 ("MAR"). In addition, market soundings (as defined in MAR) were taken in respect of the Placing with the result that certain persons became aware of inside information (as defined in MAR), as permitted by MAR. This inside information is set out in this announcement. Therefore, those persons that received inside information in a market sounding are no longer in possession of such inside information relating to the Company and its securities.

LONDON, UK / ACCESSWIRE / January 30, 2020 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) ("Hemogenyx" or the "Company"), the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce that the Company has raised £648,200 (before expenses) through a placing and subscription of 36,011,116 ordinary shares of 1p each (the "Placing Shares") at a price of 1.8p per share (the "Placing Price"). The Company has raised the maximum amount allowable under its existing authorities to issue shares for cash.

The funds raised will be used:

to continue the development and in vivo testing of the Company's Chimeric Antigen Receptor (CAR) programmed T cells (HEMO-CAR-T) against Acute Myeloid Leukemia (AML), as recently announced;
for the commercialisation of the Company's ApbHC mouse model (advanced humanised mice);
to pursue the development of protocols and treatments derived from the Company's humanised mice, including work on auto-immune diseases such as (but not restricted to) its existing lupus project; and
to provide additional working capital for the Company to progress its core CDX antibody collaboration and to support its various partnerships with other major pharmaceutical companies.

This is Hemogenyx's first equity fundraise since the completion of the reverse takeover and listing in October 2017 and the Directors are very pleased with the considerable progress that has been achieved on limited resources. Work on the core CDX antibody project with the Company's major pharmaceutical partner continues to progress with successful results achieved in further laboratory tests and with discussions ongoing as to its future development and funding. The separate development of a treatment for AML using HEMO-CAR-T has shown encouraging results to date and additional projects using the Company's ApbHC mice are under development.

The Directors are greatly encouraged by the overall progress made both with the CDX antibody project and by the number and quality of the new developments arising from this original core work.

Sir Marc Feldman, Chairman, commented, "We are pleased to have raised these funds which will allow us to advance our product pipeline. It is gratifying to see the Company's remarkable progress being recognised by investors and we see this as a vote of confidence in Hemogenyx. We welcome our new shareholders on board in the hope that they share and participate in the Company's future development and success."

Director Participation

Peter Redmond, a Non-Executive Director of the Company is subscribing for 555,556 ordinary shares in the Placing. Following completion of the Placing, Mr Redmond will be interested in 5,596,270 ordinary shares representing 1.4% of the enlarged share capital.

Admission

The Company has raised £648,200 before expenses through the issue of the Placing Shares. An application has been made for the Placing Shares to be admitted to the Official List of the UK Listing Authority by way of a Standard Listing ("Admission") and it is expected that Admission will become effective and that dealing in the Placing Shares will commence on or around 5 February 2020. The Placing Shares will rank pari passu with the existing ordinary shares of the Company.

Total Voting Rights

Following Admission, the enlarged issued share capital of the Company will comprise 397,253,969 ordinary shares of 1p each. No ordinary shares are held in Treasury. The total number of voting rights in the Company is therefore 397,253,969. The figure of 397,253,969 ordinary shares may be used by shareholders of the Company as the denominator for the calculations by which they will determine if they are required to notify their investment in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMR") and persons closely associated with them ("PCA"):

1.

Details of PDMR/person closely associated with them

a)

Name

Peter Redmond

b)

Position/status

Non-Executive Director

c)

Initial notification/
amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of 1p of Hemogenyx Pharmaceuticals plc
Identification code GB00BYX3WZ24

b)

Nature of the transaction

Allotment of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP £0.018

555,556

d)

Aggregated information

– Aggregated volume

– Price

Price(s)

Volume(s)

GBP £10,000.01

555,556

e)

Date of the transaction

30-01-2020

f)

Place of the transaction

London Stock Exchange
XLON

Enquiries:

Hemogenyx Pharmaceuticals plc

www.hemogenyx.com

Dr Vladislav Sandler, Chief Executive Officer & Co-Founder

headquarters@hemogenyx.com

Peter Redmond, Director

SP Angel Corporate Finance LLP

Tel: +44 (0)20 3470 0470

Matthew Johnson, Vadim Alexandre, Soltan Tagiev

Peterhouse Capital Limited

Tel: +44 (0)20 7469 0930

Lucy Williams, Duncan Vasey, Charles Goodfellow

US Media enquiries

Tel: +1 (323) 646-3249

Lowell Goodman

lowell@corbomitecomms.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Hemogenyx Pharmaceuticals plc

ReleaseID: 574635

NEW YORK, NY / ACCESSWIRE / January 30, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Net 1 UEPS Technologies, Inc. (NASDAQ:UEPS)

Class Period: September 12, 2018 – November 8, 2018

Deadline: February 3, 2020
For more info: www.bgandg.com/ueps

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company lacked effective internal control over financial reporting; (2) the Company had misclassified its investment in Cell C Proprietary Limited; (3) the Company's financial statements for the fiscal year 2018 were overstating its income; and (4) as a result, UEPS's public statements were materially false and misleading at all relevant times.

X Financial (NYSE:XYF)

Class Period: X Financial American Depositary Shares ("ADSs") pursuant and/or traceable to the Company's September 19, 2018 initial public offering (the "IPO")

Deadline: February 7, 2020
For more info: www.bgandg.com/xyf

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company's total loan facilitation amount was not growing, but rather was contracting; (2) the number of investors actively using X Financial's platform was shrinking; (3) demand from small- and medium-sized enterprises for the Company's Xiaoying Preferred Loans ("preferred loans") was plummeting; (4) the Company's preferred loans had performed so poorly that it had begun drastically scaling back its preferred loans in the first quarter of 2018, several months before the IPO, and was in the process of phasing out such loans completely; (5) demand for the Company's Xiaoying Card Loans was also plummeting; (6) the revenue and loan facilitation growth provided in the Registration Statement leading up to the IPO was achieved by relaxed credit and due diligence standards, under which the Company had underwritten tens of millions of dollars' worth of poor quality loans that suffered from a disproportionately high risk of default as compared to the Company's earlier loan vintages; (7) the Company was suffering from accelerated delinquency rates from poor quality loans that it had underwritten in the first, second, and third quarters of 2018, which had caused the Company's delinquency rate to sharply rise; (8) the Company's product mix had significantly deteriorated; (9) the Company's net revenue was on track to decline by 22% during the third quarter of 2018; and (10) as a result, defendants' statements about X Financial's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 571117